Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Open Access
- 26 February 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (9) , 1909-1918
- https://doi.org/10.1182/blood-2008-09-178459
Abstract
Type 5 adenovirus (Ad5) is a human pathogen that has been widely developed for therapeutic uses, with only limited success to date. We report here the novel finKeywords
This publication has 42 references indexed in Scilit:
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivoProceedings of the National Academy of Sciences, 2008
- Coating of adeno‐associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antiseraThe Journal of Gene Medicine, 2008
- Adenovirus infections and lung diseaseCurrent Opinion in Pharmacology, 2007
- Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearanceBlood, 2006
- The Coxsackievirus and Adenovirus Receptor Interacts with the Multi-PDZ Domain Protein-1 (MUPP-1) within the Tight JunctionJournal of Biological Chemistry, 2004
- Monitoring of Adenovirus Infection in Pediatric Transplant Recipients by Quantitative PCR: Report of Six Cases and Review of the LiteratureAmerican Journal of Transplantation, 2004
- Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor InteractionJournal of Virology, 2003
- Structure and Chromosomal Localization of the Murine Coxsackievirus and Adenovirus Receptor GeneDNA and Cell Biology, 2003
- Complement activation by recombinant adenovirusesGene Therapy, 2001